Comera Life Sciences Holdings, Inc. (CMRA) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Comera Life Sciences Holdings, Inc. (CMRA) Bundle
Designed for accuracy, our (CMRA) DCF Calculator empowers you to evaluate Comera Life Sciences Holdings, Inc. valuation using real-time financial data, offering complete flexibility to modify all essential parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
FY1 2023 |
FY2 2024 |
FY3 2025 |
FY4 2026 |
FY5 2027 |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .4 | .3 | .6 | .9 | 1.2 | 1.6 | 2.1 | 2.8 | ||
| Revenue Growth, % | 0 | -27.79 | 97.95 | 35.08 | 35.08 | 35.08 | 35.08 | 35.08 | ||
| EBITDA | -2.0 | -5.4 | -17.9 | -.9 | -1.2 | -1.6 | -2.1 | -2.8 | ||
| EBITDA, % | -460.08 | -1676.81 | -2825.23 | -100 | -100 | -100 | -100 | -100 | ||
| Depreciation | .1 | .1 | .1 | .2 | .2 | .3 | .4 | .6 | ||
| Depreciation, % | 20.26 | 27.77 | 14.84 | 20.96 | 20.96 | 20.96 | 20.96 | 20.96 | ||
| EBIT | -2.1 | -5.5 | -18.0 | -.9 | -1.2 | -1.6 | -2.1 | -2.8 | ||
| EBIT, % | -480.34 | -1704.58 | -2840.07 | -100 | -100 | -100 | -100 | -100 | ||
| Total Cash | .2 | 6.5 | .4 | .6 | .8 | 1.1 | 1.4 | 2.0 | ||
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | ||
| Account Receivables | .1 | .2 | .0 | .3 | .4 | .5 | .7 | 1.0 | ||
| Account Receivables, % | 26.02 | 69.27 | 5.42 | 33.57 | 33.57 | 33.57 | 33.57 | 33.57 | ||
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .1 | ||
| Inventories, % | 4.95 | 0.62533 | 0 | 1.86 | 1.86 | 1.86 | 1.86 | 1.86 | ||
| Accounts Payable | .1 | .4 | 1.5 | .6 | .9 | 1.2 | 1.6 | 2.1 | ||
| Accounts Payable, % | 22.04 | 130.36 | 230.34 | 74.01 | 74.01 | 74.01 | 74.01 | 74.01 | ||
| Capital Expenditure | .0 | -.1 | .0 | -.1 | -.2 | -.3 | -.4 | -.5 | ||
| Capital Expenditure, % | -2.79 | -44.4 | -4.52 | -17.24 | -17.24 | -17.24 | -17.24 | -17.24 | ||
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EBITAT | -2.1 | -5.3 | -18.0 | -.8 | -1.1 | -1.5 | -2.1 | -2.8 | ||
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2.1 | -5.1 | -16.7 | -1.9 | -1.0 | -1.3 | -1.8 | -2.4 | ||
| WACC, % | 4.45 | 4.32 | 4.45 | 4.41 | 4.41 | 4.41 | 4.41 | 4.41 | ||
| PV UFCF | ||||||||||
| SUM PV UFCF | .0 | .0 | .0 | .0 | .0 | .0 | .0 | -7.4 | ||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -2 | |||||||||
| Terminal Value | -103 | |||||||||
| Present Terminal Value | -83 | |||||||||
| Enterprise Value | -90 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -91 | |||||||||
| Diluted Shares Outstanding, MM | 10 | |||||||||
| Equity Value Per Share | -8.66 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real CMRA financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Quickly observe the impact of your inputs on Comera Life Sciences' valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive CMRA Data: Pre-filled with Comera Life Sciences' historical financials and future growth projections.
- Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax percentages, and capital expenditures.
- Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Testing: Develop various forecast scenarios to evaluate different valuation outcomes.
- User-Friendly Design: Intuitive, organized, and crafted for both industry professionals and newcomers.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Comera Life Sciences Holdings, Inc.'s (CMRA) pre-filled financial data and forecasts.
- Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Watch the DCF model update instantly as you tweak assumptions.
- Step 5: Analyze the outputs and use the results for investment decisions.
Why Choose Comera Life Sciences Holdings, Inc. (CMRA)?
- Innovative Solutions: Cutting-edge technology tailored for the life sciences industry.
- Enhanced Efficiency: Streamlined processes that save time and resources for your projects.
- Data-Driven Insights: Leverage reliable analytics to make informed decisions.
- Customizable Services: Flexible options to meet your specific research and development needs.
- Expert Support: A dedicated team of professionals committed to your success.
Who Should Use This Product?
- Investors: Assess Comera Life Sciences Holdings, Inc.’s (CMRA) valuation prior to making investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and evaluate financial forecasts.
- Startup Founders: Discover how leading biotech firms like Comera are valued in the market.
- Consultants: Create comprehensive valuation reports for your clientele.
- Students and Educators: Utilize current market data to learn and teach valuation strategies.
What the Template Contains
- Pre-Filled DCF Model: Comera Life Sciences' financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Comera Life Sciences' profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.